Kiora Pharmaceuticals Inc

NASDAQ:KPRX 1:00:00 PM EDT

2.85

-0.01 (-0.35%)

4:45:58 PM EDT: $2.90 +0.05 (+1.75%)

Market Cap (Intraday)	8.67M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.75 Million
Adjusted EPS	-$0.61

See more estimates

10-Day MA	$2.92
50-Day MA	$3.12
200-Day MA	$3.33

See more pivots

Kiora Pharmaceuticals Inc Stock, NASDAQ:KPRX

332 Encinitas Boulevard, Suite 102, Encinitas, California 92024

United States of America

Phone: +1.858.224.9600

Number of Employees: 12

http://www.kiorapharma.com

Description

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.